Adopting clinical recommendations will stimulate development of competition in health care

07-04-2017 | 08:33

Timophey Nizhegorodtsev: their role is of crucial importance for fair competition on the markets of medical services, medicinal drugs and medical products

The spring session of the Inter-Parliamentary Assembly of the CIS member-states (IPA CIS) took part in Taurida Palace on 26-27 March 2017.

The event included meetings of the Ongoing IPA CIS Commission of on various sectors as well as more than 35 bilateral meetings between Heads of Parliamentary delegations.

On 27 March, Head of FAS Department for Control over Social Sphere and Trade Timophey Nizhegorodtsev took part in IPA CIS Expert Council in Health Care. The expert discussion focused on clinical medicine in the XXI cent. and the need to develop clinical recommendations in view of regional factors and determining the position of those recommendations in the health care system. The Expert Council also discussed a set of issues related to the status, order and procedures for devising clinical recommendations and the legal consequences of introducing them.

Special attention was paid to taking clinical recommendations into account by medical doctors in their everyday practice as well as the mechanism of devising and legalizing such recommendations, and the procedure for holding medical doctors liable for failure to execute mandatory requirements provided for by the recommendations.

Participants underlined the importance of clinical recommendations for stimulating competition in health care. “Clinical recommendations is not a simple system of coordinates in rendering health care in the field of medical services, their role is crucially important on the markets of medical services, drugs and medical products”, emphasized Timophey Nizhegorodtsev.

The Expert Council also discussed international requirements to the processes related to health care organization and the avenues for enhancing efficiency in the CIS. The utmost importance and timeliness of raising the issue of preparing clinical recommendations was stressed. The discussion will be continued at the next session of the Expert Council.



Site Map

News & Events Press Releases Image Library About FAS Russia What We Do Institutional Memory Mission, Goals, Values Priority Setting Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings Using our website International Cooperation Treaties & Agreements OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 OECD meetings 2019 OECD meetings 2020 OECD meetings 2021 FAS Annual Reports OECD-GVH RCC RCC Newsletter Projects ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD 18th session IGE UNCTAD 8th UN Conference on Competition 19th session IGE UNCTAD 20th session IGE UNCTAD 21th session IGE UNCTAD EEU Model Law on Competition ICN BRICS BRICS Conferences Documents BRICS Competition Law and Policy Centre BRICS Working Groups for the Research of Competition Issues in Socially Important markets Working Group for the Research of Competition Issues in the Pharmaceutical Markets Working Group for the Research of Competition Issues in the Food Value Chains Working Group for the Research of Competition Issues in the Automobile Markets Working Group for the Research of Competition Issues in the Digital Markets BRICS Coordination Committee on antimonopoly policy EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Document Library Legislation Reports & Analytics Cases & decisions COVID-19 Contacts Give feedback Contact us Links Authorities Worldwide